Utah state officials and health experts are warning the public against the use of mislabeled and illegal kratom products that may contain dangerous synthetic alkaloids, following concerns regarding overdoses linked to adulterated substances. The Utah Department of Agriculture and Food and the Utah Poison Control Center are urging consumers to verify product safety to avoid the risks associated with unregulated products in the state's specialized products market.
Potency and Overdose Risks
The risks associated with kratom products are increasing due to the presence of concentrated alkaloids. According to the Utah Poison Control Center in a July 22 report, adulterated products, such as certain Cat’s Claw and Kava products, may cause opioid overdoses. This risk is heightened by the presence of 7-hydroxymitragynine (7-OH), a naturally occurring alkaloid in the kratom plant that is significantly more potent than the plant's primary alkaloid, mitragynine.
While 7-OH is a minor constituent making up less than 2% of the total alkaloid content in natural kratom leaves, it demonstrates substantially greater mu-opioid receptor potency than mitragynine and other classical opioids like morphine. The Utah Department of Agriculture and Food notes that products containing 7-OH at a concentration greater than 0.4% of the alkaloid fraction are considered illegal. Furthermore, any products containing synthetic alkaloids, such as synthetic mitragynine or synthetic 7-hydroxymitragynine, are prohibited.
Utah Regulatory Standards
The Utah Department of Agriculture and Food (UDAF) oversees the manufacturing and sale of specialized products, including kratom, tobacco, and cannabinoids. The UDAF Kratom Program is designed to protect consumer health by enforcing standards set by the Utah Kratom Registration Act, which includes registering and inspecting all kratom products sold within the state.
To ensure safety, the UDAF Specialized Products Division requires that kratom can only be sold from a Specialty Tobacco Retail Business with a license that specifically covers kratom. Consumers are advised to only purchase pure leaf kratom that appears on the state's Registered Product List. These listed products have undergone review and testing to ensure compliance with state safety and labeling standards.
Federal Regulatory Status
The Food and Drug Administration (FDA) has maintained that kratom is not appropriate for use as a dietary supplement. The agency has concluded that kratom is a new dietary ingredient for which there is inadequate information to provide reasonable assurance that it does not present a significant or unreasonable risk of illness or injury. Consequently, dietary supplements containing kratom are considered adulterated under the FD&C Act.
Additionally, the FDA has determined that kratom is an unsafe food additive and cannot be lawfully added to conventional foods. The agency continues to warn the public against using kratom for medical treatment, noting that no prescription or over-the-counter drug products containing kratom or its known alkaloids are legally on the market in the United States. The FDA is currently monitoring emerging data trends to better understand the substance and its components.
Health and Contamination Risks
The health implications of kratom use can be severe and unpredictable. The Utah Department of Agriculture and Food reports that kratom can lead to physical dependence and addiction due to its opioid-like effects, with withdrawal symptoms similar to those of traditional opioids.
Rare but serious adverse health effects have been reported, including problems related to the gastrointestinal, cardiovascular, respiratory, and psychiatric systems, as well as hepatotoxicity. Furthermore, kratom products have been found to be contaminated with pathogenic bacteria like Salmonella and heavy metals, including nickel and lead. Because kratom can interact with other substances and prescription medications, it can lead to dangerous and unpredictable health outcomes.
Utah Overdose Trends
The urgency of addressing drug-related deaths is underscored by data from the Utah Public Overdose Dashboard. According to the dashboard, drug poisoning deaths are the leading cause of injury death in Utah, outpacing deaths from motor vehicle crashes, falls, and firearms.
As of 2025, it is estimated that 11 Utahns die each week from drug overdose. While prescription opioid overdoses have historically been a major concern, deaths from prescription opioids have continued to trend downward. In contrast, methamphetamine surpassed fentanyl in 2024 as the most commonly involved drug in overdoses. The dashboard tracks these trends to inform drug overdose prevention efforts across the state.
Consumer Safety and Reporting
To promote consumer safety, the Utah Department of Agriculture and Food encourages residents to be informed consumers. This includes checking whether a product manufacturer publishes its own test results and ensuring that items are clearly labeled on receipts, as retailers who misidentify items may be attempting to conceal non-compliant products.
If a consumer experiences an adverse reaction, the Utah Poison Control Center provides a free and private 24-hour resource for immediate phone support at 1-800-222-1222. Additionally, the UDAF provides a platform for consumers to file complaints regarding kratom products or retail establishments that they believe violate state requirements.
Scientific Research and Alkaloids
The complexity of the kratom market involves various alkaloids. While mitragynine is the most prevalent alkaloid and acts as a partial agonist at mu-opioid receptors, kratom contains over 50 other alkaloids, including paynantheine, speciogynine, and mitraphylline. The specific roles of these minor alkaloids are not yet fully understood, though they may contribute to the plant's overall effects.
Ongoing research is being driven by the increasing use of kratom and the necessity of understanding its safety and efficacy. Researchers continue to investigate these compounds to better understand how they interact with the human body and to mitigate the risks associated with potential misuse.
